HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Steven P. Goldberg William L. Holman Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Davies, J. E. Articles by Holman, W. L. Search for Related Content PubMed PubMed Citation Articles by Davies, J. E. Articles by Holman, W. L.

Ann Thorac Surg 2005;80:1408-1416
© 2005 The Society of Thoracic Surgeons

---

Original article: Cardiovascular

Multiple Treatment Approach to Limit Cardiac Ischemia-Reperfusion Injury

^a Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama
^b Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama
^c Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama

Accepted for publication April 14, 2005.

^_* Address reprint requests to Dr Holman, University of Alabama at Birmingham, Birmingham, AL35294-0007 (Email: wholman{at}its.uab.edu).

BACKGROUND: This study evaluates a multiple treatment approach (ie, pharmacologic preconditioning [diazoxide], sodium-proton exchange inhibition [cariporide], and controlled reperfusion) to improve the outcome from severe cardiac ischemia-reperfusion injury that occurs during a cardiac operation.

METHODS: Five groups of 10 pigs (group 1: control, group 2: diazoxide, group 3: cariporide, group 4: controlled reperfusion, and group 5: combination of diazoxide and cariporide-controlled reperfusion) underwent 75 minutes of left anterior descending occlusion, 1 hour of cardioplegic arrest, and 2 hours of reperfusion. Prior to occlusion, each group received an infusion of vehicle alone (ie, dimethylsulfoxide for the control and the controlled reperfusion groups) or vehicle with drug (ie, diazoxide or cariporide, or both for all other groups). Infarct size (primary outcome) was measured and was normalized to the region at risk. Regional function (secondary outcome) was measured using preload recruitable work area.

RESULTS: Infarct size as a function of area at risk was decreased by cariporide-controlled reperfusion, and combination treatment compared with the control group (14 ± 6%, 15 ± 8%, and 9 ± 4% vs 24 ± 9%; p < 0.02), and variation in infarct size was decreased by combination treatment compared with the controlled reperfusion group alone (p < 0.02). Recovery of systolic function during reperfusion significantly improved in the left anterior descending region in the cariporide and combination groups compared with the control, controlled reperfusion, or diazoxide groups (group-time effect, p < 0.05).

CONCLUSIONS: Combined use of controlled reperfusion, cariporide, and diazoxide decreases myocyte necrosis and loss of systolic function compared with an untreated control group. Combination treatment has the potential to improve the results of cardiac surgery, however further improvements are needed before clinical application.

This article has been cited by other articles:

				R. M. Mentzer Jr Invited commentary Ann. Thorac. Surg., October 1, 2005; 80(4): 1416 - 1416. [Full Text] [PDF]